A Study of Avelumab Plus Axitinib in Non-Small Cell Lung Cancer or Urothelial Cancer

A Phase 2, Open Label Study to Evaluate Safety and Clinical Activity of Avelumab (BAVENCIO®) in Combination With Axitinib (INLYTA®) in Patients With Advanced or Metastatic Previously Treated Non-Small Cell Lung Cancer or Treatment Naïve Cisplatin-Ineligible Urothelial Cancer (JAVELIN Medley VEGF)

Category & Conditions: Cancer

Medicine: Bavencio (avelumab)

ClinicalTrials.gov Identifier (NCT): NCT03472560

Protocol ID:https://clinicaltrials.gov/study/NCT03472560?term=NCT03472560&rank=1

Print Download

Open Plain Language Summary Result: Click here